Skip to content

Paromomycin

Antiprotozoal — ALIMENTARY TRACT AND METABOLISM

Also known as: ameparomo, aminosidin, aminosidine, catenulin, crestomycin, paromomycin sulfate, paromomycin sulphate, paromomycine, paucimycin

OfpFDA approvedATC A07AA06

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Paromomycin is an ofp drug in the Antiprotozoal class catalogued in DrugCentral. It was first approved by the FDA in 1969. Recorded indications include Acute amebiasis, Chronic intestinal amebiasis and Hepatic coma.

  • Approval status: ofp (first approved 1969 by the FDA).
  • Drug class: Antiprotozoal.
  • Indications: Acute amebiasis, Chronic intestinal amebiasis and Hepatic coma.
  • ATC code: A07AA06 (Antibiotics).
  • Molecular formula: C23H45N5O14; molecular weight 615.63 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Acute amebiasis
  • Chronic intestinal amebiasis
  • Hepatic coma

Off-label uses (2)

  • Infection by Cryptosporidium
  • Intestinal Parasitic Infections

Contraindications (5)

  • Disorder of the 8th Cranial Nerve
  • Gastrointestinal obstruction
  • Gastrointestinal ulcer
  • Hearing loss
  • Kidney disease

Mechanism & targets

Established pharmacologic classAntiprotozoal

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1969-03-24FDA——

ATC classification

ATC codeTherapeutic hierarchy
A07AA06ALIMENTARY TRACT AND METABOLISM › ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS › INTESTINAL ANTIINFECTIVES › Antibiotics

Chemical structure

Molecular formulaC23H45N5O14
Molecular weight615.63 g/mol
CAS number—
InChIKeyUOZODPSAJZTQNH-LSWIJEOBSA-N
PubChem CID165580
NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Paromomycin used for?

DrugCentral lists the following indications for Paromomycin: Acute amebiasis, Chronic intestinal amebiasis and Hepatic coma.

When was Paromomycin first approved?

Paromomycin was first approved by the FDA in 1969.

What drug class does Paromomycin belong to?

Paromomycin is in the Antiprotozoal class.

What is the chemical formula of Paromomycin?

Paromomycin has the molecular formula C23H45N5O14 and a molecular weight of 615.63 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1969-03-24
AgencyFDA
Targets0
Indications3
FormulaC23H45N5O14
DrugCentral ID2067
Interactive profile